| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |